Healthx and Pharmaceutical Strategies Group (PSG), the nation's leading pharmacy benefits consulting firm, have joined together to provide complete Pharmacy Benefits transparency, audited continuously, for the sake of building long term, cost-effective customer relationships. We offer a free analysis of potential savings for an employer group, based on their current situation.
The operations of pharmacy benefit managers can be complex. Direct contracting for PBM services under the traditional pricing model yields approximately $3-$5 per claim in earned revenue for the PBM. Forty-six percent of PBM earned revenue comes from network and dispensing fees, while 54% is generated through the manufacturer relationship. Healthx offers a truly transparent alternative that utilizes Walgreens Health Initiatives (WHI) as the PBM. With the Healthx arrangement, WHI will receive total revenue of $0.75 per claim.
Simply asking for a transparency model does not guarantee receipt. Auditing verifies the accuracy of plan design loading, pricing, and rebate guarantees. This means confirmation that WHI passes through 100% of all rebate monies, as well as network discounts for brand and generic at both retail and mail. With the exception of educational dollars, WHI is also passing through ALL manufacturer revenue.
Our offering combines fully transparent PBM pricing based on aggregated volume purchasing with minimum guarantees, low net costs after rebates (PBM’s interests are aligned with client’s interests), superior web-based data reporting, 90-day supply at retail, clear and fair contract wording, and extensive performance guarantees.
PSG’s deep clinical expertise and abilities (9 clinical PharmDs) are an integrated part of the total offering. For example:
Our consulting services include benchmarking, clinical expertise and best practices as well as oversight of PBM services provided by Walgreens Health Initiatives (WHI).
The purchasing coalition has a proven track record of savings based on improved PBM pricing alone, without considering lower net costs through a cost-effective formulary. Savings for seven employers covering 75-1,320 employees, ranged from 4.4% to 12.0% of annual drug spend.
Copyright Healthx, Inc. 2008